Eugen Laboratries Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 K
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Eugen Laboratries
Eugen Laboratries Private Limited (ELPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 September 2016 (Eight years and five months 23 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 K , as per Ministry of Corporate Affairs (MCA) records.
Chandrasekhararao Valluru and Abishek Valluru serve as directors at the Company.
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33112AP2016PTC103991
- Company No.
103991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Sep 2016
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Eugen Laboratries?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abishek Valluru  | Managing Director | 01-Sep-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekhararao Valluru | Director | 20-Jan-2022 | Current |
Financial Performance of Eugen Laboratries.
Eugen Laboratries Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Eugen Laboratries?
In 2017, Eugen Laboratries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Abeera Beverages Private LimitedChandrasekhararao Valluru and Abishek Valluru are mutual person
- Bnb Infracon India Private Limited
Chandrasekhararao Valluru and Abishek Valluru are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eugen Laboratries?
Unlock and access historical data on people associated with Eugen Laboratries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugen Laboratries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugen Laboratries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
